Advertisement

European Journal of Epidemiology

, Volume 32, Issue 2, pp 159–163 | Cite as

The prevalence of multiple non-communicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study

  • Huandong Lin
  • Qian Li
  • Yu Hu
  • Chouwen Zhu
  • Hui Ma
  • Jian Gao
  • Jiong Wu
  • Hong Shen
  • Wenhai Jiang
  • Naiqing Zhao
  • Yiqing Yin
  • Baishen Pan
  • Johannes Jeekel
  • Albert Hofman
  • Xin Gao
LETTER TO THE EDITOR

Abstract

Objective

We set out to study the prevalence and combination of multiple non-communicable diseases among middle-aged and elderly people in the Shanghai Changfeng community, China.

Methods

A cross-sectional survey through questionnaire, physical, and laboratory examinations, color ultrasound and DXA was performed on a typical sample of 6038 residents (ages greater than 45-years-old) from the Shanghai Changfeng community between June 2009 and December 2012.

Results

The prevalence of chronic diseases (rating from high to low) was as follows: hypertension (55.3%), dyslipidemia (33.5%), diabetes (21.9%), obesity (12.4%), and osteoporosis (9.3%). There were sex-specific and age-specific differences in these diseases. Just less than half (40.5%) the study population suffered from two or more chronic diseases. Hypertension patients were more likely to suffer from obesity, diabetes, dyslipidemia, and risk factors for cardiovascular diseases, but not osteoporosis. The most common combination of multiple diseases was hypertension with dyslipidemia (9.95%) or diabetes (6.61%).

Conclusion

In the Chinese middle-aged and elderly population, the most common multiple non-communicable diseases, including hypertension, dyslipidemia, diabetes, and obesity should be controlled to prevent cardiovascular disease.

Keywords

Prevalence Chronic diseases Community-based cohort study middle-aged and elderly population 

Abbreviations

NCD

Non-communicable diseases

WC

Waist circumference

HC

Hip circumference

BMI

Body mass index

WHR

Waist to hip ratio

BP

Blood pressure

FBG

Fasting blood glucose

TC

Total cholesterol

TG

Triglycerides

HDL-C

High-density lipoprotein-cholesterol

LDL-C

Low-density lipoprotein-cholesterol

2hBG

2-hour blood glucose

OGTT

Oral glucose tolerance test

NGSP

National Glycated Haemoglobin Standardization Program

BMD

Bone mineral density

OP

Osteoporosis

DXA

Dual-energy x-ray absorptiometry

SBP

Systolic blood pressure

DBP

Diastolic blood pressure

CVD

Cardiovascular disease

Notes

Acknowledgements

This work was sponsored by the National Key Basic Research Program of China (Grant No. 2012CB524906 to X. Gao), the Shanghai Municipal Health Project Grant (Grant No. 2013ZYJB0802 to X. Gao), the Shanghai Health and Family Planning Commission Foundation (Grant Nos. 12GWZX0103 and 2013SY005 to X. Gao), and the Shanghai Hospital Development Center Foundation (SHDC12012201 to X. Gao).

Authors’ contribution

Study conception and design: XG, AH and JJ. Site inspection and data collection: HL, QL, YH, CZ and HM. Sample examination: JW and BP. Data management: HL, JG, HS, WJ and YY. Data analysis: HL, JG, NZ and XG. Manuscript preparation: HL and QL. Manuscript revision: XG and AH.

Compliance with ethical standards

Conflict of interest

All authors have declared that they have no conflicts of interest.

References

  1. 1.
    Lozano R, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMedGoogle Scholar
  2. 2.
    Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Hofman A, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28(11):889–926.CrossRefPubMedGoogle Scholar
  4. 4.
    Gao X, et al. The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol. 2010;25(12):885–93.CrossRefPubMedGoogle Scholar
  5. 5.
    Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(5):390–419.Google Scholar
  6. 6.
    Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.PubMedGoogle Scholar
  7. 7.
    Bao Y, et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis. 2008;201(2):378–84.CrossRefPubMedGoogle Scholar
  8. 8.
    Li D, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–44.CrossRefPubMedGoogle Scholar
  9. 9.
    Pan L, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis. 2016;248:2–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Xu Y, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59.CrossRefPubMedGoogle Scholar
  11. 11.
    Hou X, et al. Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLoS ONE. 2013;8(3):e57319.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16(1):1039.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • Huandong Lin
    • 1
    • 2
  • Qian Li
    • 1
    • 2
  • Yu Hu
    • 3
  • Chouwen Zhu
    • 4
  • Hui Ma
    • 3
  • Jian Gao
    • 5
  • Jiong Wu
    • 6
  • Hong Shen
    • 7
  • Wenhai Jiang
    • 7
  • Naiqing Zhao
    • 8
  • Yiqing Yin
    • 7
  • Baishen Pan
    • 6
  • Johannes Jeekel
    • 9
  • Albert Hofman
    • 10
  • Xin Gao
    • 1
    • 2
  1. 1.Department of Endocrinology and Metabolism, Shanghai Zhongshan HospitalFudan UniversityShanghaiChina
  2. 2.Fudan Institute for Metabolic DiseasesShanghaiChina
  3. 3.Department of Geriatrics, Clinical Epidemiology Center, Shanghai Zhongshan HospitalFudan UniversityShanghaiChina
  4. 4.Department of Foreign AffairsFudan UniversityShanghaiChina
  5. 5.Department of Clinical Nutrition, Shanghai Zhongshan HospitalFudan UniversityShanghaiChina
  6. 6.Department of Laboratory Medicine, Zhongshan HospitalFudan UniversityShanghaiChina
  7. 7.Network Information Center, Shanghai Zhongshan HospitalFudan UniversityShanghaiChina
  8. 8.Department of Biostatistics, School of Public HealthFudan UniversityShanghaiChina
  9. 9.Department of NeuroscienceErasmus Medical CenterRotterdamThe Netherlands
  10. 10.Department of EpidemiologyErasmus Medical CenterRotterdamThe Netherlands

Personalised recommendations